Stepwise relationship between components of metabolic syndrome and risk of colorectal adenoma in a taiwanese population receiving screening colonoscopy

Journal of the Formosan Medical Association

Volumn 110, Issue 2, 2011, Pages 100-108

  Hu, Nien Chih ^a   Chen, Jong Dar ^a,b,d   Lin, Yu Min ^c,d   Chang, Jun Yih ^a   Chen, Yu Hung ^a  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b Ctr Res Environ and Occup Dis   (Taiwan)

^c Division of Gastroenterology   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Abdominal obesity; Colorectal adenoma; Metabolic syndrome

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL EXAMINATION;

EID: 79955596602     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(11)60016-8     Document Type: Article

References (35)

1. Hu G, Qiao Q, Tuomilehto J. The metabolic syndrome and cardiovascular risk. Curr Diabetes Rev 2005;1:137-43.
2. Guize L, Pannier B, Thomas F, et al. Recent advances in metabolic syndrome and cardiovascular disease. Arch Cardiovasc Dis 2008;101:577-83.
3. Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 2007;132:2208-25.
4. Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005;365:1398-405.
5. Hsing AW, Gao YT, Chua S Jr, et al. Insulin resistance and prostate cancer risk. J Natl Cancer 2003;95:67-71.
6. Russo A, Autelitano M, Bisanti L. Metabolic syndrome and cancer risk. Eur J Cancer 2008;44:293-7.
7. Pollak M. Insulin, insulin-like growth factors and neoplasia. Best Pract Res Clin En 2008;22:625-38.
8. Bruce WR, Wolever TM, Giacca A. Mechanism linking diet and colorectal cancer. The possible role of insulin resistance. Nutr Cancer 2000;37:19-26.
9. Chiu HM, Lin JT, Chen HH, et al. Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men. Am J Gastroenterol 2008;103: 2317-25.
10. Marugame T, Lee K, Eguchi H, et al. Relation of impaired glucose tolerance and diabetes mellitus to colorectal adenomas in Japan. Cancer Causes Control 2002;13:917-21.
11. Keku TO, Lund PK, Galanko J, et al. Insulin resistance, apoptosis, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2005;14:2076-81.
12. Hamilton SRVB, Kudo S, Riboli E, et al. Tumors of the colon and rectum. In: Hamilton SR, et al, eds. World Health Organization Classifications of Tumors: Pathology and Genetics of Tumors of the Digestive System. Lyon: IARC, 2000.
13. Kim JH, Lim YJ, Kim YH, et al. Is metabolic syndrome risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev 2007;16:1543-6.
14. Chiu HM, Lin JT, Shun CT, et al. Association of metabolic syndrome with proximal and synchronous colorectal neoplasm. Clin Gastroenterol Hepatol 2007;5:221-9.
15. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancr: a review. Am J Clin Nutr 2007;86:S836-42.
16. Tran TT, Naigamwalla D, Oprescu AI, et al. Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo. Endocrinology 2006;147:1830-7.
17. Tran TT, Medline A, Bruce WR. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 1996;5: 1013-5.
18. LeRoith D, Baserga R, Helman L, et al. Insulin-like growth factors and cancer. Ann Intern Med 1995;122:54-9.
19. Renehan AG, Zwahlen M, Minder C, et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363:1346-53.
20. Tsushima M, Nomura AM, Lee J, et al. Prospective study of the association of serum triglyceride and glucose with colorectal cancer. Digest Dis Sci 2005;50:499-505.
21. Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70000 events. Cancer Epidemiol Biomarkers Prev 2007;16:2533-47.
22. Chung YW, Han DS, Park YK, et al. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Digest Liver Dis 2006;38:668-72.
23. Lee GE, Park HS, Yun KE, et al. Association between BMI and metabolic syndrome and adenomatous colonic polyps in Korean men. Obesity 2008;16:1434-9.
24. Morita T, Tabata S, Mineshita M, et al. The metabolic syndrome is associated with increased risk of colorectal adenoma development: the Self-Defense Forces health study. Asian Pac J Cancer Prev 2005;6:485-9.
25. Giorgino F, Laviola L, Eriksson JW. Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol Scand 2005;183: 13-30.
26. Kim YJ, Kim YJ, Lee S. An association between colonic adenoma and abdominal obesity: a cross-sectional study. BMC Gastroenterol 2009;9:4.
27. Erlinger TP, Platz EA, Rifai N, et al. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004;291: 585-90.
28. Kern AP, Ranganathan S, Li C, et al. Adipose tissue tumor necrosis and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001;280:E745-51.
29. Lamb RE, Goldstein BJ. Modulating an oxidativeinflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function. Int J Clin Pract 2008;62:1087-95.
30. Toshie O, Kousaku U, Ryota T, et al. C-reactive protein and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci 2009;100:709-14.
31. Colca JR. Insulin sensitizers may prevent metabolic inflammation. Biochem Pharmacol 2006;72:125-31.
32. Bao YQ. Jia WP. Chen L, et al. Association between Creactive protein level and metabolic syndrome and components thereof. Chinese Med J 2006;86:2105-9.
33. Wang YY, Lin SY, Lai WA, et al. Association between adenomas of recto-sigmoid colon and metabolic syndrome features in a Chinese population. J Gastroenterol Hepato. 2005;20:1410-5.
34. Botteri E, Iodice S, Raimondi S, et al. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology 2008;134:388-95.
35. Terry MB, Neugut AI, Bostick RM, et al. Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2002;11:622-9.